Original paper

Assessment of tumor enhancement by contrast‐enhanced CT in solid tumor‐bearing dogs treated with toceranib phosphate

Volume: 61, Issue: 4, Pages: 427 - 434
Published: Mar 11, 2020
Abstract
In humans, contrast‐enhanced CT (CECT) has been used to indirectly assess the antiangiogenic effects demonstrated by a number of tyrosine kinase inhibitors. This retrospective, cross‐sectional study aimed to quantitatively evaluate changes in tumor contrast‐enhancement (CE) using CECT in solid tumor‐bearing dogs treated with toceranib phosphate (TOC). The changes in tumor size and CE were measured using the Hounsfield unit (HU) scale in CECT...
Paper Details
Title
Assessment of tumor enhancement by contrast‐enhanced CT in solid tumor‐bearing dogs treated with toceranib phosphate
Published Date
Mar 11, 2020
Volume
61
Issue
4
Pages
427 - 434
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.